Hard to Treat Diseases Inc. (HTDS)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 6, 2026
Market Cap5.82K
Revenue (ttm)6.16M
Net Income974.30K
EPS0.00
Shares Out5.82B
PE Ratio0.01
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume22,000
Average Volume1,415,945
Open0.0000
Previous Close0.0000
Day's Range0.0000 - 0.0000
52-Week Rangen/a
Beta0.42
RSI51.46
Earnings Daten/a

About Hard to Treat Diseases

Hard to Treat Diseases Inc. manufactures, supplies, and exports human vaccines and biological products in China and internationally. The company offers human vaccines, such as recombinant human papillomavirus bivalent, freeze-dried live attenuated hepatitis A, recombinant hepatitis E, meningococcal polysaccharide, 23-valent pneumococcal polysaccharide, varicella, rabies, group ACYW135meningococcal conjugate, inactivated poliomyelitis, enterovirus Type 71, influenza, meningococcal Group A, C bivalent polysaccharide conjugate, recombinant hepatit... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Country United States
Stock Exchange OTCMKTS
Ticker Symbol HTDS
Full Company Profile